Navigation Links
YM BioSciences Reports Fiscal First Quarter 2011 Operational and Financial Results
Date:11/11/2010

multiforme.

Other highlights:

  • YM announced that Pulmokine Inc. (Slingerlands, New York), a licensee of several small molecule compounds from YM, has been awarded two National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants. The grants, totaling more than US$650,000, are Phase I awards to develop novel treatments for Pulmonary Arterial Hypertension (PAH).

  • Subsequent to quarter end, Dr. Nick Glover will be appointed as Chief Executive Officer of the Company to be effective at the Company's Annual General Meeting on November 18, 2010. Dr. Glover is also nominated to stand for election as a Director of the Company at that time. Mr. David Allan, who has been Chairman of the Company since its founding in 1994 and CEO since 1998, will continue to serve as Chairman of YM's Board of Directors.

  • Subsequent to quarter end, Dr. Mark Kowalski joined YM BioSciences as Chief Medical Officer and Vice President, Regulatory Affairs. Dr. Kowalski was formerly the Chief Medical Officer and Vice President, Regulatory Affairs at Viventia Biotechnology Inc., a biopharmaceutical company involved in the discovery and development of monoclonal antibody-based technologies for the treatment of cancer. Prior to joining Viventia, Dr. Kowalski was the Director, and then Senior Director of Medical Affairs at AAIPharma Inc. Dr. Kowalski holds a B.A. from Rutgers University, and a M.D. and Ph.D. from the University of Kansas School of Medicine. He completed his postgraduate training in Internal Medicine and Infectious Diseases at Duke University and Harvard Medical School.
  • Financial Results (CDN dollars) Total revenue for the first quarter of fiscal 2011, ended September 30, 2010, was $0.4 million compared to $0.7 million for the first quarter of fiscal 2010, ended September 30, 2009. Revenue from licensees was $0.3 million for first quarter of fiscal 2011 compared to $0.7 million for the f
    '/>"/>

    SOURCE YM BioSciences Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. YM BIOSCIENCES REPORTS SIGNIFICANT RESPONSE RATES IN ANEMIA, SPLENOMEGALY, AND CONSTITUTIONAL SYMPTOMS FROM THE PHASE I/II TRIAL OF ITS JAK1/JAK2 INHIBITOR, CYT387, IN MYELOFIBROSIS
    2. Regado Biosciences Awarded Three Grants from the Federal Government to Advance Research of Lead Programs
    3. Sangamo BioSciences Awarded Grants for the Development of Four ZFP Therapeutic® Programs
    4. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
    5. X-BODY BioSciences Awarded Grant for Therapeutic Discovery Project Targeting Metastatic Tumor Stem Cells
    6. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
    7. Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City
    8. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
    9. Sangamo BioSciences Announces Third Quarter 2010 Conference Call and Webcast
    10. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
    11. Cell Biosciences to Acquire Convergent Bioscience
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/26/2014)... , Aug. 26, 2014 An analysis ... structures of all Dengue virus strains in Pubmed, has ... back to 1944. This conservation and sharing of specific ... Synthetic Dengue Blocker-Vaccine™ candidate, as it did for the ... both of which have been found to be effective ...
    (Date:8/26/2014)... , Aug. 26, 2014   Lycera Corp ... breakthrough oral medicines to treat autoimmune disease and ... today announced the appointment of Harinder Singh ... advisory board.  Dr. Singh will lead the board,s ... Lycera,s multiple ongoing research programs and pipeline of ...
    (Date:8/26/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
    (Date:8/26/2014)... (PRWEB) August 26, 2014 Genedata, ... drug discovery and life science research, today announced ... will be held in Asia, Europe, and ... global pharmaceutical companies and leading research organizations will ... best practices, case studies, and upcoming challenges in ...
    Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3
    ... Sept. 20 HelixLife™ recently launched the following ... (Vitamins & Skin Serum), Anti-Acne Skin Serum, Foundational ... lines were developed in partnership with GeneLink BioSciences, ... personal health and skin care using GeneLink,s advanced ...
    ... Sept. 20 Epitomics, Inc. today announced that The ... chosen the company to distribute a panel of LRRK2 ... the two parties. Under a special arrangement the antibodies ... PD research community to help advance LRRK2 therapeutic development ...
    ... a central alternative to petroleum-based energy production. However, current ... yield and is more expensive to mass-produce. In addition, ... on the environment is incomplete, experts say. To ... of solar power, a research team from Rochester Institute ...
    Cached Biology Technology:HelixLife Launches Custom Health Supplements, Anti-Aging and Acne Skin Serums 2Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation 2Research team assesses environmental impact of organic solar cells 2
    (Date:8/26/2014)... , August 26, 2014 ... von Oxygen Forensic Passware Analyst bekannt, einem ... preisgekrönten Erfassungs- und Analysetools von Oxygen mit ...     Das neue Tool kombinierte ... einem einzigen nahtlosen Ablauf. Das neu hinzugekommene ...
    (Date:8/25/2014)... of the first U.S. outbreaks of the H1N1 virus ... 2,000 people. A university math and biology professor has ... to gain insight into how only a few infected ... university community., The fall 2009 semester hadn,t even started ... Health and Wellness Services clinic11 one day, and just ...
    (Date:8/25/2014)... University of California, San Diego School of Medicine have found ... the primary form of a deadly brain cancer are ... DNA sequence of the tumor, but in its epigenetic signature. ... in the journal Oncotarget . , "There is ... DNA of the cancer cell," said Clark Chen, MD, PhD, ...
    Breaking Biology News(10 mins):Oxygen Forensic Passware Analyst erfasst geschützte Mobilgerätedaten 2WSU flu outbreak provides rare study material 2WSU flu outbreak provides rare study material 3Finding keys to glioblastoma therapeutic resistance 2
    ... why Starbucks puts boxes of breath mints close to the ... in your mouth, strong enough to startle your co-workers too. ... by renowned breath specialist Prof. Mel Rosenberg of TAU,s Sackler ... the bacteria that lead to bad breath. New laboratory tests ...
    ... in German . , Mitochondria are ... harbor an elaborately folded inner membrane. It holds a ... cavities (cristae). The narrow shape of the entrance or ... the intracristal space and storage of molecules. Cytochrome c, ...
    ... and Wilfrid Laurier University today announce the launch ... a visible point of open access archiving of ... community. Built on BioMed Central,s "Open ... access knowledge and technology experience, Laurier IR is ...
    Cached Biology News:A breath mint made from... coffee? 2How mitochondria get their membranes bent 2'Canadian excellence' strengthened by extensive adoption of open access 2
    Recombinant Rhesus Monkey IFN Alpha Activity: 2.9 x 10 8 u/mg...
    ... space and organize gloves, safety glasses, ... are the perfect benchtop storage bins ... processing and manufacturing. Clear static-dissipative PVC ... they attract. Many other sizes and ...
    ... Ultrapure C 25 H 27 N 2 ... PRODUCT SPECIFICATIONS Form: Dark burgundy metallic powder Identity: ... 2 O, 1 cm): greater than or equal ... Drying: less than or equal to 10.0% lambda ...
    ...
    Biology Products: